All posts tagged: weight

New Foundayo weight loss pill approved by FDA

New Foundayo weight loss pill approved by FDA

Get the Well Enough newsletter with Harry Bullmore for tips on living a healthier, happier and longer life Get the Well Enough email with Harry Bullmore Get the Well Enough email with Harry Bullmore Federal regulators have approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The FDA granted expedited approval to orforglipron, a GLP-1 drug that works like widely used injectable medications to mimic a natural hormone that controls appetite and feelings of fullness. The drug, which will be branded as Foundayo, is expected to begin shipping Monday. The company said people with insurance may be able to get the drug starting at $25 per month with a Lilly discount card. Prices for people paying cash will range between $149 per month to $349 per month, depending on the dose. The new pill joins drugmaker Novo Nordisk’s oral Wegovy pill, which has spurred more than 600,000 prescriptions in the United States since it was approved in December. Both the Lilly and Novo Nordisk pills resulted …

Donna Ashworth exclusive: ‘The noise around weight loss jabs can be triggering after battling anorexia – but I’ve found tools to cope’

Donna Ashworth exclusive: ‘The noise around weight loss jabs can be triggering after battling anorexia – but I’ve found tools to cope’

When poet Donna Ashworth bounced into the Second Act podcast studio she was like a ray of sunshine, full of positivity and vitality.  The bestselling poet revealed she has finally, aged 50, managed to find ways to tweak her brain and lead a relatively peaceful life which, having suffered from anorexia and OCD,  since she was a schoolgirl, feels like a massive feat. It was a deeply personal chat and what she was keen to share was that being aware of the triggers that can lead into these conditions is the first step in getting help and taking back control of your busy mind. By sharing her emotional story she hopes she will help others become aware earlier of potential issues that need to be dealt with, and then seek help before it spirals out of control. Donna Ashworth with Ateh Jewel in the Second Act studio With the rise in people getting easy access to weight loss jabs, Donna feels that, now more than ever, people who have suffered from anorexia are feeling vulnerable …

Air India Flight Attendants’ Pay Now Depends On Their Weight

Air India Flight Attendants’ Pay Now Depends On Their Weight

An airline’s latest policy regarding its flight attendants’ appearance has left many people flabbergasted. Air India recently announced that their cabin crew would have to start paying close attention to their weight unless they wanted to be on the receiving end of a pay cut.  According to multiple reports, flight attendants working for Air India will have to keep an eye on their Body Mass Index (BMI) readings, as guidelines now require that they be within a certain “range” to be compensated at all. If you’re thinking it only applies to bigger bodies, think again; being too thin is grounds for pay being withheld as well. Air India introduced a new policy for flight attendants whose pay now depends on their weight. Air India cabin crew will reportedly face leave without pay if they are underweight or overweight based on BMI readings following its new Cabin Crew Health and Fitness Compliance Policy, which takes effect on May 1. The policy categorizes a BMI range between 18 and 24.9 as “normal” and acceptable for flight, per …

More than a million to be prescribed weight loss drug to prevent heart attacks and strokes | UK News

More than a million to be prescribed weight loss drug to prevent heart attacks and strokes | UK News

More than a million people with heart disease will be prescribed a weight loss jab to prevent them from having heart attacks or strokes. The NHS’s spending watchdog, the National Institute for Health and Care Excellence (NICE), has approved giving semaglutide to overweight and obese patients living with certain heart and circulatory conditions to cut their risk of a major cardiovascular event. The weekly jab, sold under the brand name Wegovy, is a GLP-1 receptor agonist – a type of drug that encourages weight loss by slowing down how quickly food is digested. NICE said clinical trials have also indicated the drug works directly on the heart and blood vessels – and it expects that 1.2 million people across England could benefit. Guidance says the treatment can be used by patients with a body mass index (BMI) score of 27 and above in addition to other medicines, such as statins, and alongside a reduced-calorie diet and increased exercise. You need javascript enabled to view this content Enable javascript to share Share Weight loss drugs may …

The surprising case for less meal variety when losing weight

The surprising case for less meal variety when losing weight

Hunger may not be the most challenging aspect of losing weight. One of the biggest challenges could be making hundreds of food choices every day. One day you might eat a salad, then a wrap the next day, followed by a smoothie. Then a healthy-looking snack that was actually unhealthy. Conversely, in a culture that revolves around new foods on a regular basis, this study suggests that eating fewer different foods repetitively over time, and therefore having a more consistent caloric intake throughout the week, will help you lose weight. This study out of Health Psychology follows 112 overweight or obese adults in the first 12 weeks of a behavioral weight loss program. It found a clear-cut pattern: the more a person’s food logs showed an increase in repetitions, the more weight they lost. Dr. Charlotte Hagerman, PhD, lead author of this research and researcher with the Oregon Research Institute, says, “It takes constant effort and self-control to maintain a healthy diet in today’s food environment. Creating an eating routine will reduce this effort and …

FDA Approves Higher-Dose Wegovy To Help People Lose More Weight

FDA Approves Higher-Dose Wegovy To Help People Lose More Weight

By HealthDay Staff HealthDay ReporterMONDAY, March 23, 2026 (HealthDay News) — A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher dose. The U.S. Food and Drug Administration (FDA) approved a 7.2-milligram dose of Novo Nordisk’s semaglutide, the active ingredient in Wegovy. Until now, the highest approved dose was 2.4 milligrams, taken as a weekly shot. The new version, called Wegovy HD, went through an accelerated review and was approved just 54 days after the application was accepted, the agency said. Novo Nordisk said the higher-dose shot is expected to be available in the U.S. in April, when the price is to be announced. The higher dose was tested in a study that tracked people for nearly 17 months. Participants who took the stronger dose lost about 19% of their body weight, or about 47 pounds on average. People taking the lower dose lost about 16% (or roughly 39 pounds). Researchers said that the higher dose may help people who don’t see enough …

Is it true that … you need to work out if you want to lose weight? | Life and style

Is it true that … you need to work out if you want to lose weight? | Life and style

In order to lose weight, most people need to maintain a calorie deficit over a sustained period, says Bethan Crouse, a performance nutritionist at Loughborough University. “This can be done by increasing exercise to boost your calorie expenditure and therefore create a deficit,” she says. “In that case, exercise might be the key to losing weight. But you could approach it the other way: by choosing less calorie-dense foods and reducing your energy intake, you can create a deficit without changing how much you exercise.” Relying on workouts alone for weight loss can be challenging. “If you’re aiming to burn an extra 300 to 500 calories a day, that’s an awful lot of exercise. You’re likely to need some kind of nutritional intervention as well to create that gap between energy intake and output.” She recommends focusing on diet, ensuring meals are built around a good source of protein, plenty of vegetables and fruit, healthy fats and a wholegrain carbohydrate – but don’t make carbs the majority of the meal. When it comes to movement, Crouse suggests thinking about overall …

Gogglebox’s Amy Tapper’s weight loss transformation in photos

Gogglebox’s Amy Tapper’s weight loss transformation in photos

Former Gogglebox star Amy Tapper revealed she lost eight stone after embarking on a health and fitness journey following her stint on the Channel 4 reality show that ended in 2018.  The 26-year-old TV personality has been documenting her diet and exercise routines on her social media platforms and recently shared that she had been taking weight loss medication in addition to living a healthier lifestyle.  She has been injecting herself with Mounjaro and has seen her weight drop from a size 26 to a size 18 in just 12 months. Amy has been incorporating exercise into her daily routine with the help of her personal trainer, Natasha Ram, who revealed the star had lost eight stone on Instagram.  Sharing a comparison video to her page, showing the star at her biggest and her current weight, Amy tagged Natasha in the post and added a caption that said: “Looking back so I never forget how far I’ve come. Eight stone, two pounds gone forever.”  The star, who rose to fame when her family appeared on …

Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds

Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds

By HealthDay Staff HealthDay ReporterFRIDAY, March 20, 2026 (HealthDay News) — Drugs like Ozempic and Mounjaro are known to lower the risk of heart attack and stroke, but a new study suggests those benefits may not last if people stop taking them. Researchers found that heart risks begin to rise again within six months after stopping GLP-1 medications, and much of the benefit may be gone within about 18 months. “It takes a whole lot longer to build or accrue benefit, and then half as much to erase all that benefit,” study author Dr. Ziyad Al-Aly, a clinical epidemiologist at Washington University in St. Louis, told CNN. “For example, what took three years to build — three years of the cardiovascular benefit — was actually erased or undone with just one and a half years of stopping,” he added. The study — published March 18 in BMJ Medicine — reviewed medical records from more than 333,000 people with type 2 diabetes treated through the Veterans Health Administration. Researchers compared about 132,000 patients who took GLP-1 …